"icotinib" meaning in All languages combined

{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "icotinib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Organic compounds",
          "orig": "en:Organic compounds",
          "parents": [
            "Matter",
            "Chemistry",
            "Nature",
            "Sciences",
            "All topics",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 April 22, Yan Wang, Yan Sun, “Clinical experiences with molecular targeted therapy in lung cancer in China”, in Thoracic Cancer, volume 6, →DOI:",
          "text": "Clinical studies on the R&D of new drugs, represented by icotinib and endostatin, also suggest a bright future in China of the development of clinical oncology and the further improvement of the cure rate in patients with advanced NSCLC.",
          "type": "quote"
        }
      ],
      "glosses": [
        "The epidermal growth factor receptor tyrosine kinase inhibitor N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine"
      ],
      "id": "en-icotinib-en-noun-F~ZYPeRP",
      "links": [
        [
          "organic chemistry",
          "organic chemistry"
        ],
        [
          "epidermal",
          "epidermal"
        ],
        [
          "growth factor",
          "growth factor"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "tyrosine",
          "tyrosine"
        ],
        [
          "kinase",
          "kinase"
        ],
        [
          "inhibitor",
          "inhibitor"
        ]
      ],
      "raw_glosses": [
        "(organic chemistry) The epidermal growth factor receptor tyrosine kinase inhibitor N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine"
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "chemistry",
        "natural-sciences",
        "organic-chemistry",
        "physical-sciences"
      ],
      "wikipedia": [
        "icotinib"
      ]
    }
  ],
  "word": "icotinib"
}

{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "icotinib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms with quotations",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Organic compounds"
      ],
      "examples": [
        {
          "ref": "2015 April 22, Yan Wang, Yan Sun, “Clinical experiences with molecular targeted therapy in lung cancer in China”, in Thoracic Cancer, volume 6, →DOI:",
          "text": "Clinical studies on the R&D of new drugs, represented by icotinib and endostatin, also suggest a bright future in China of the development of clinical oncology and the further improvement of the cure rate in patients with advanced NSCLC.",
          "type": "quote"
        }
      ],
      "glosses": [
        "The epidermal growth factor receptor tyrosine kinase inhibitor N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine"
      ],
      "links": [
        [
          "organic chemistry",
          "organic chemistry"
        ],
        [
          "epidermal",
          "epidermal"
        ],
        [
          "growth factor",
          "growth factor"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "tyrosine",
          "tyrosine"
        ],
        [
          "kinase",
          "kinase"
        ],
        [
          "inhibitor",
          "inhibitor"
        ]
      ],
      "raw_glosses": [
        "(organic chemistry) The epidermal growth factor receptor tyrosine kinase inhibitor N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine"
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "chemistry",
        "natural-sciences",
        "organic-chemistry",
        "physical-sciences"
      ],
      "wikipedia": [
        "icotinib"
      ]
    }
  ],
  "word": "icotinib"
}